Oroten HCT Tablet 5/40/12.5 mg
Amlodipine Besylate · Olmesartan Medoxomil +1 more
Prescription medication · Combination
Korea Pharma Co., Ltd.
MFDS item code 201805364 · Approved 2018.12.28
This product's status changed to Approval withdrawn on 2023.06.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement in blood pressure control for essential hypertension
For patients with essential hypertension, if blood pressure is not adequately controlled with the combination therapy of amlodipine and olmesartan medoxomil, additional treatment may be necessary. These two drugs work by dilating blood vessels and blocking the causes of elevated blood pressure. However, sometimes blood pressure control may be difficult with either single or combination therapy alone, so it is important to consult with healthcare professionals to consider adjusting medications or exploring other treatment options. This helps manage blood pressure more effectively and reduce the risk of cardiovascular diseases. It is helpful in treating essential hypertension.
This medication is taken once daily, with one tablet taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5 mg: administered to patients for whom blood pressure is not adequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/20 mg. - 5/40/12.5 mg: administered to patients for whom blood pressure is not adequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/40 mg.
The safety and efficacy for pediatric patients under 18 years have not been established, so administration of this medication is not recommended.
This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it must not be taken during pregnancy. If pregnancy is confirmed, discontinue use immediately. Patients who have had allergies or hypersensitivity reactions to this medication or any of its components, women who are pregnant or breastfeeding, patients with severe hypotension or serious heart conditions, patients with severe kidney or liver diseases, and patients with electrolyte imbalances should not take this medication. Patients with reduced blood volume or electrolyte imbalances may experience hypotension; thus, the condition should be confirmed before administration, and continuous monitoring is required after treatment initiation. If hypotensive symptoms occur, rest immediately by lying down and administer fluids if necessary. This medication may affect kidney function, so patients with decreased kidney function should regularly check their kidney function and electrolyte status through blood tests. Particular caution is required when administering this medication to patients with liver disease or severe cirrhosis, certain heart valve diseases, systemic lupus erythematosus patients, and elderly individuals. This medication can cause photosensitive reactions on the skin, so avoid excessive exposure to sunlight or ultraviolet rays and consult a doctor immediately if any skin abnormalities arise. Dizziness or drowsiness may occur while taking this medication, so caution should be exercised when driving or engaging in hazardous activities. Drug interactions may occur when taken with other medications, especially lithium, diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and other antihypertensive medications; patients should consult with their doctor or pharmacist if taking these drugs. In cases of overdose, severe hypotension or heart problems may occur, requiring immediate emergency treatment, so caution is necessary to avoid exceeding the prescribed dosage. Safety and efficacy have not been established for children, and use is not recommended; elderly patients should start at a low dose considering reduced kidney and liver function. Store this medication in a location out of reach of children, and keep it away from moisture, heat, and direct sunlight.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy.
Pale yellow round film-coated tablet
28 tablets (14 tablets/PTP × 2) / carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate · Olmesartan Medoxomil +1 more
Prescription medication · Combination
Korea Pharma Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.